BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 26152227)

  • 1. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
    Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
    Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats.
    Gi M; Fujioka M; Totsuka Y; Matsumoto M; Masumura K; Kakehashi A; Yamaguchi T; Fukushima S; Wanibuchi H
    Mutagenesis; 2019 Sep; 34(3):279-287. PubMed ID: 31233596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.
    Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Uehara N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F; Wakabayashi K; Totsuka Y
    Jpn J Cancer Res; 2002 Oct; 93(10):1076-82. PubMed ID: 12417036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.
    Tsuda H; Takahashi S; Yamaguchi S; Ozaki K; Ito N
    Carcinogenesis; 1990 Apr; 11(4):549-52. PubMed ID: 2322995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
    Tsuda H; Fukushima S; Wanibuchi H; Morimura K; Nakae D; Imaida K; Tatematsu M; Hirose M; Wakabayashi K; Moore MA
    Toxicol Pathol; 2003; 31(1):80-6. PubMed ID: 12597451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen.
    Hoshi M; Morimura K; Wanibuchi H; Wei M; Okochi E; Ushijima T; Takaoka K; Fukushima S
    Toxicol Sci; 2004 Oct; 81(2):273-9. PubMed ID: 15282409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens.
    Fukushima S; Gi M; Fujioka M; Kakehashi A; Wanibuchi H; Matsumoto M
    Toxicol Res; 2018 Oct; 34(4):291-296. PubMed ID: 30370003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Hepatocarcinogenicity of Combinations of Low Doses of 2-amino-3, 8-dimethylimidazo[4,5- f ]quinoxaline and Diethylnitrosamine in Rats: Indication for the Existence of a Threshold for Genotoxic Carcinogens.
    Wei M; Kakehashi A; Yamano S; Tamano S; Shirai T; Wanibuchi H; Fukushima S
    J Toxicol Pathol; 2012 Sep; 25(3):209-14. PubMed ID: 22988339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
    Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
    Waddell WJ; Fukushima S; Williams GM
    Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.
    Murai T; Mori S; Kang JS; Morimura K; Wanibuchi H; Totsuka Y; Fukushima S
    Toxicol Pathol; 2008 Apr; 36(3):472-7. PubMed ID: 18413788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.
    Sone H; Wakabayashi K; Kushida H; Ochiai M; Sugimura T; Nagao M
    Jpn J Cancer Res; 1993 Aug; 84(8):859-64. PubMed ID: 8407550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative DNA damage caused by carbon tetrachloride-induced liver injury -- enhancement of MeIQ-induced glutathione S-transferase placental form-positive foci in rats.
    Iwai S; Karim R; Kitano M; Sukata T; Min W; Morimura K; Wanibuchi H; Seki S; Fukushima S
    Cancer Lett; 2002 May; 179(1):15-24. PubMed ID: 11880177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
    Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
    Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
    Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.
    Fujita K; Ohnishi T; Sekine K; Iigo M; Tsuda H
    Jpn J Cancer Res; 2002 Jun; 93(6):616-25. PubMed ID: 12079509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose carcinogenicity of a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: relevance to risk assessment.
    Fukushima S
    Cancer Lett; 1999 Sep; 143(2):157-9. PubMed ID: 10503896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats.
    Ichihara T; Wanibuchi H; Totsuka Y; Morimura K; Wei M; Nakae D; Fukushima S
    Cancer Sci; 2004 Dec; 95(12):943-8. PubMed ID: 15596042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol.
    Wanibuchi H; Wei M; Karim MR; Morimura K; Doi K; Kinoshita A; Fukushima S
    Toxicol Pathol; 2006; 34(3):232-6. PubMed ID: 16698719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.